Lipids and lipid binding proteins: A perfect match

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 93, Issue , 2015, Pages 45-49

  Glatz, Jan F C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

CD36; Fatty acid signaling; Fatty acid binding protein; Lipid binding protein; Lipid bio availability

Indexed keywords

CD36 ANTIGEN; CYTOPLASMIC FATTY ACID BINDING PROTEIN; FATTY ACID; FATTY ACID BINDING PROTEIN 1; FATTY ACID BINDING PROTEIN 2; FATTY ACID BINDING PROTEIN 3; FATTY ACID BINDING PROTEIN 4; FATTY ACID BINDING PROTEIN 4 INHIBITOR; FATTY ACID BINDING PROTEIN 7; LIPID; LIPID BINDING PROTEIN; MEMBRANE ASSOCIATED FATTY ACID BINDING PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; FATTY ACID BINDING PROTEIN;

ARTICLE; DRUG PROTEIN BINDING; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; HUMAN; LIVER INJURY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; ANIMAL; CELL MEMBRANE; LIPID METABOLISM; METABOLISM;

ANIMALS; CELL MEMBRANE; FATTY ACID-BINDING PROTEINS; LIPID METABOLISM;

EID: 84922819662     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.07.011     Document Type: Article

References (36)

1. Glatz J.F.C., Van der Vusse G.J. Cellular fatty acid-binding proteins: their function and physiological significance. Prog. Lipid Res. 1996, 35:243-282.
2. Schaap F.G., Van der Vusse G.J., Glatz J.F.C. Evolutuion of the family of intracellular lipid binding proteins in vertebrates. Mol. Cell. Biochem. 2002, 239:69-77.
3. Storch J., Thumser A.E. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 2010, 285:32679-32683.
4. Su X., Abumrad N.A. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol. Metab. 2009, 20:72-77.
5. Glatz J.F.C., Luiken J.J.F.P., Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev. 2010, 90:367-417.
6. Kazantzis M., Stahl A. Fatty acid transport proteins, implications in physiology and dieases. Biochim. Biophys. Acta 1821, 2012:852-857.
7. Ockner R.K., Manning J.A., Poppenhausen R., Ho W. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardioum and other tissues. Science 1972, 177:56-58.
8. Smathers R.L., Petersen D.R. The human fatty acid-binding protein family: evolutionary divergences and functions. Hum. Genome 2011, 5:170-191.
9. Vorum H., Brodersen R., Kragh-Hansen U., Pedersen A.O. Solubility of long-chain fatty acids in phosphate buffer at pH 7.4. Biochim. Biophys. Acta 1992, 1126:135-142.
10. Richieri G.V., Kleinfeld A.M. Unbound free fatty acid levels in human serum. J. Lipid Res. 1995, 36:229-240.
11. Vork M.M., Glatz J.F.C., Van der Vusse G.J. On the mechanisms of long chain fatty acid transport in cardiomyocytes as facilitated by cytoplasmic fatty acid-binding protein. J. Theor. Biol. 1993, 160:207-222.
12. Glatz J.F.C., Luiken J.J.F.P., Van Nieuwenhoven F.A., Van der Vusse G.J. Molecular mechanism of cellular uptake and intracellular translocation of fatty acids. Prostaglandines Leukot. Essent. Fatty Acids 1997, 57:3-9.
13. Schaap F.G., Binas B., Danneberg H., Van der Vusse G.J., Glatz J.F.C. Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid-binding protein gene. Circ. Res. 1999, 85:329-337.
14. Luiken J.J.F.P., Koonen D.P.Y., Coumans W.A., Pelsers M.M.A.L., Binas B., Bonen A., Glatz J.F.C. Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice. Lipids 2003, 38:491-496.
15. Reese-Wagoner A., Thompson J., Banaszak L. Structural properties of the adipocyte lipid binding protein. Review. Biochim. Biophys. Acta 1999, 1441:106-116.
16. Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J. Appl. Genet 2006, 47:39-48.
17. Furuhashi M., Hotamisligil G.S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. 2008, 7:489-503.
18. Furuhashi M., Tuncman G., Görgün C., Makowski L., Atsumi G., Vaillancourt E., Kono K., Babaev V.R., Fazio S., Linton M.F., Sulsky R., Robl J.A., Parker R.A., Hotamisligil G.S. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007, 447:959-965.
19. Hoo R.L.C., Lee I.P.C., Zhou M., Wong J.Y.L, Hui X., Xu A., Lam K.S.L. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. J. Hepatol. 2013, 58:358-364.
20. Bonen A., Chabowksi A., Luiken J.J.F.P., Glatz J.F.C. Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical and physiological evidence. Physiology 2007, 22:15-28.
21. Hamilton J.A. New insights into the roles of proteins and lipids in membrane transport of fatty acids. Prostaglandines Leukot. Essent. Fatty Acids 2007, 77:355-361.
22. Stremmel W., Strohmeyer G., Borchard F., Kochwa S., Berk P.D. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc. Natl. Acad. Sci. U.S.A 1985, 82:4-8.
23. Roepstorff C., Helge J.W., Vistisen B., Kiens B. Studies of plasma membrane fatty acid-binding protein and other lipid-binding proteins in human skeletal miscle. Proc. Nutr. Soc. 2004, 63:239-244.
24. Dutta-Roy A.K. Transport of fatty acids across the human placenta: a review. Prog. Lipid Res. 2009, 48:52-61.
25. Silverstein R.L., Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2009, 2:re3.
26. Degrace-Passilly P., Besnard P. CD36 and taste of fat. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15:107-111.
27. Clarke D.C., Miskovic D., Han X.X., Calles-Escandon J., Glatz J.F.C., Luiken J.J.F.P., Heikkila J.J., Bonen A. Overexpression of membrane associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol. Genomics 2004, 17:31-37.
28. Stremmel W., Pohl L., Ring A., Herrmann T. A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids 2001, 36:981-989.
29. Bonen A., Luiken J.J.F.P., Arumugam Y., Glatz J.F.C., Tandon N.N. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 2000, 275:14501-14508.
30. Lauzier B., Merlen C., Vaillant F., McDuff J., Bouchard B., Beguin P.C., Dolinsky V.W., Foisy S., Villeneuve L.R., Labarthe F., Dyck J.R.B., Allen B.C., Charron G., Des Rosiers C. Post-translocational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart. J. Mol. Cell. Cardiol. 2011, 51:99-108.
31. Smith J., Su X., El-Maghrabi R., Stahl P.D., Abumrad N.A. Oppositie regulation of CD36 ubiquitination by fatty acids and insulin. J. Biol. Chem. 2008, 283:13578-13585.
32. Kim K.-Y., Stevens M.V., Akter M.H., Rusk S.E., Huang R.J., Cohen A., Noguchi A., Springer D., Bocharov A.V., Eggerman T.L., Suen D.-F., Youle R.J., Amar M., Remaley A.T., Sack M.N. Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J. Clin. Invest. 2011, 121:3701-3712.
33. Geloen A., Helin L., Geeraert B., Malaud E., Holvoet P., Marguerie G. CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis. PloS One 2012, 7:e37633.
34. Bessi V.L., Labbé S.M., Huynh D.N., Ménard L., Jossart C., Febbraio M., Guérin B., Bentourkia M., Lecomte R., Carpentier A.C., Ong H., Marleau S. EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice. Cardiovasc. Res. 2012, 96:99-108.
35. Angin Y., Steinbusch L.K.M., Simons P.J., Greulich S., Hoebers N.T.H., Douma K., Van Zandvoort M.A.M.J., Coumans W.A., Wijnen W., Diamant M., Ouwens D.M., Glatz J.F.C., Luiken J.J.F.P. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes. Biochem. J. 2012, 448:43-53.
36. Febbraio M., Guy E., Coburn C., Knapp F.F., Abumrad N.A., Silverstein R.L. The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36. Mol. Cell. Biochem. 2002, 239:193-197.